2006-06-01
Thyrotropin, but not a polymorphism in type II deiodinase, predicts response to paroxetine in major depression
Publication
Publication
European Journal of Endocrinology , Volume 154 - Issue 6 p. 819- 825
Objective: The determinants of response to antidepressant treatment in major depression are unknown at present. The aim of the present study was to establish whether response is predicted by Hypothalamus-Pituitary-Thyroid (HPT) axis parameters or by a recently discovered polymorphism in the enzyme type II deiodinase (DII), which catalyzes the production of T3 in the brain. Design: We analyzed predi ction of response to paroxetine treatment by calculating response rates per tertile of HPT-axis parameters and per DII genotype. Methods: Ninety-eight outpatients with major depression ( DSM-IV) were included. Serum concentrations of TSH, FT4 and delta TSH in a DEX/ CRH-TRH test were measured. In addition, the presence of a polymorphism in the DII sequence (Thr92AIa) was determined. Results: The overall tre atment response was 48 of 98 patients (49%). After exclusion of patients with subclinical hypothyroidism and/or TPO antibodies (n = 16), higher serum TSH significantly predicted response (response rate per tertile from low to high TSH: 36%, 42%, and 67%). Heterozygous patients for the DII polymorphism (44%) had slightly lower serum TSH (P = 0.03) as compared to patients with the wild-type DII (47%). The polymorphism was unrelated to treatment response. Conclusion: Higher serum TSH was associated with response to paroxetine in patients with major depression.
| Additional Metadata | |
|---|---|
| doi.org/10.1530/eje.1.02155, hdl.handle.net/1765/54594 | |
| European Journal of Endocrinology | |
| Organisation | Department of Cardiology |
|
Brouwer, J., Wiersinga, W., Fliers, E., Appelhof, B., Peeters, R., Hoogendijk, W., Huyser, J., Schene, A., Tijssen, J., van Dyck, R.& Visser, T. (2006). Thyrotropin, but not a polymorphism in type II deiodinase, predicts response to paroxetine in major depression. European Journal of Endocrinology, 154(6), 819–825.https://doi.org/10.1530/eje.1.02155 |
|